Procurement Summary
Country : Ukraine
Summary : Ibuprofen Tablets/Capsules of 200 Mg; Albendazole Tablets of 400 Mg; Azithromycin Tablets/Capsules of 500 Mg; Cefotaxime, Powder for Injection of 1 G; Cefissim Tablets/Capsules of 400 Mg; Benzylbenzoate ...
Deadline : 16 Apr 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 117596108
Document Ref. No. : UA-2025-04-11-003164-a
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : UAH 240000
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Ibuprofen tablets/capsules of 200 mg; Albendazole tablets of 400 mg; Azithromycin tablets/capsules of 500 mg; Cefotaxime, powder for injection of 1 g; Cefissim tablets/capsules of 400 mg; Benzylbenzoate Emulsion Semphirne, 200 mg/g, 50 g in a vial; Hydrochlorothiazide tablets of 25 mg; Salbutamol, inhalation under pressure, 100 mcg/dose, 200 doses; Salts for oral rehydration, oral powder, 18.9 g; Ascorbic acid tablets of 500 mg; Glibenclamide tablets of 5 mg; Fluoxetine capsules/tablets of 20 mg; Risperidone, tablets, 2 mg; Povdone-iodine, solution for the externaluse, 10 %, 1000 ml; Levonorgestrel, tablets, 1.5 mg; Human insulin (medium duration), suspension for injection, 100 units/ml, vial, 10 ml (according to the NW 577mg, albendazole tablets of 400 mg, azithromycin tablets/capsules of 500 mg, cefotaxime, powder for injection of 1 g, cefixim tablets/capsules of 400 mg, benzylbenzoate Emulcia Szezhirne, 200 mg/g, 50 g in 50 g. Salbutamol, inhalation under pressure, 100 mcg/dose, by200 doses, oral rehydration salts, oral powder, 18.9 g, ascorbic acid tablets of 500 mg, glibenclamide tablets of 5 mg, fluoxetine capsules/tablets of 20 mg, risperidone, tablets, 2 mg, 2 ml, didone.Levonorgestrel, tablets, 1.5 mg, human insulin (average duration), suspension for injection, 100 units/ml, vial, 10 ml
Documents
Tender Notice